Search Results
10
Everything
Search Filters
Tag
Clinical Development
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025: BioNTech, Moderna and myNEO Therapeutics Lead Race in Personalized Cancer Vaccines
March 25, 2025 09:56 ET
|
Research and Markets
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025" report has been added to ResearchAndMarkets.com's offering. ...
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
March 24, 2025 06:59 ET
|
Pasithea
Pasithea Therapeutics (KTTA) will present PAS-004 Phase 1 data at the 2025 CAGLA NeauxCancer Conference on March 28 in New Orleans.
Next-Gen Immunotherapy: Trispecific Antibodies Show 260x Potency Over Traditional Treatments
March 20, 2025 10:24 ET
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Trispecific Antibodies Clinical Trials, Fast Track Status, Technology Platforms & Market Opportunity Outlook 2025" report has been added to ...
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
March 20, 2025 09:00 ET
|
Longeveron
Longeveron reaches alignment with US FDA on single, pivotal clinical trial to BLA submission for cell therapy for treatment of Alzheimer's disease.
CD70 Targeting Therapies Clinical Trials Insight 2025: 20+ CD70 Targeting Therapies In Clinical Trials
January 31, 2025 05:00 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering. CD70...
CD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,
January 29, 2025 06:14 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. ...
Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
January 28, 2025 05:44 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
Delta-like Ligand 3 (DLL3) Targeted Therapies Market Research 2025: 1 Drug, Imdelltra (Tarlatamab) Available / 10 Drugs by Company, Indication and Phase / Approved Drug Dosage, Sales & Pricing Insight
January 23, 2025 07:51 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "DLL3 Targeted Therapies Market, Approved Drugs, Dosage, Pricing & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's...
China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT)
January 09, 2025 09:12 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar will provide...
Clinical Trials Management Systems (CTMS) Market Research, 2024-2035, by Solution Type, Component, Delivery Mode, End User, and Region with Detailed Company Profiles of Leading Players
January 03, 2025 07:29 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Management System Market by Solution Type, by Component, by Delivery Mode, by End-User, and By Region" report has been added to ...